Results 11 to 20 of about 4,860 (160)

Quantitative pretreatment VOI analysis of liver metastases 99mTc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT [PDF]

, 2013
Using quantitive VOI analysis, the percentage Tc-99m-MAA uptake and SUVmax and mean values of liver metastases obtained prior to SIRT were related to treatment response using both a lesion-based and clinical dichotomous approach. Based on the VOI % of Tc-
Beels, L, Brugman, E, D'Asseler, Yves, De Spiegeleer, Bart, Maes, A, Mees, Gilles, Stellamans, K, Van De Wiele, Christophe   +7 more
core   +2 more sources

Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution image-based efficacy and comparative toxicity [PDF]

, 2017
Aim: Compare radioembolization (Y90) and chemoembolization (CE) for the treatment of unresectable intrahepatic cholangiocarcinoma (UICC). Materials & methods: Institutional Review Board-approved, retrospective search was performed.
Akinwande, Olaguoke, Foltz, Gretchen, Mills, Abigail, Noda, Christopher, Saad, Nael, Shah, Veer, Weiner, Eric   +6 more
core   +2 more sources

Radioembolization in the setting of liver transplantation. Great expectations or hard times? [PDF]

, 2018
Trans-arterial radio-embolization (TARE) with yttrium-90 represents one of the most efficacious approaches for the treatment of selected patients with advanced hepatocellular cancer (HCC) (1).
Lai, Quirino, Mennini, Gianluca
core   +1 more source

Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives [PDF]

, 2015
In the last decade trans-arterial radioembolization has given promising results in the treatment of patients with intermediate or advanced stage hepatocellular carcinoma (HCC), both in terms of disease control and tolerability profile.
Bargellini, Irene, Bartolozzi, Carlo, Bertini, Marco, Bresci, Giampaolo, Corti, Ambra, Federici, Graziana, Giacomelli, Luca, Giorgi, Luigi, Marceglia, Sara, Metrangolo, Salvatore, Mismas, Valeria, Parisi, Giuseppe, Piccinno, Michele, Romano, Antonio, Sacco, Rodolfo, Tredici, Manuel, Tumino, Emanuele   +16 more
core   +1 more source

Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus [PDF]

, 2017
Selective internal radiation therapy (SIRT) with microspheres labelled with the β-emitter yttrium-90 (Y-90) enables targeted delivery of radiation to hepatic tumors. SIRT is primarily used to treat inoperable primary or metastatic liver tumors.
Brown, DB, Fakih, M, Feilchenfeldt, J, Gibbs, P, Kennedy, A, Knuth, A, Marshall, J, Pittari, G, Sangro, B, Sharma, RA, Soulen, MC, Wasan, H   +11 more
core   +1 more source

Radioembolization of Yttrium-90 Microspheres for Hepatic Malignancy [PDF]

Seminars in Interventional Radiology, 2008
The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of ...
Ravi, Murthy, Paresh, Kamat, Rodolfo, Nuñez, Riad, Salem   +3 more
openaire   +2 more sources

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer [PDF]

, 2014
Liver metastases from colorectal cancer (CRC) result in substantial morbidity and mortality. The primary treatment is systemic chemotherapy, and in selected patients, surgical resection; however, for patients who are not surgical candidates and/or fail ...
Bande, Dinesh, Beg, Muhammad S., Blaszkowsky, Lawrence S., Ganguli, Suvranu, Kalva, Sanjeeva P., Pillai, Anil K., Raval, Mihir   +6 more
core   +2 more sources

Yttrium-90 Microsphere Radioembolization for Hepatocellular Carcinoma

Liver Cancer, 2014
Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver malignancies, and clinical data supporting its use have accumulated in recent years. Y90-radioembolization has shown clinical effectiveness in intermediate and advanced hepatocellular carcinoma, with a favorable safety profile.
Edeline, Julien, Gilabert, Marine, Garin, Etienne, Boucher, Eveline, Raoul, Jean-Luc   +4 more
openaire   +3 more sources

Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips. [PDF]

Semin Intervent Radiol
Villalobos A, Pisanie JLD, Gandhi RT, Kokabi N.   +3 more
europepmc   +3 more sources

Planning Arteriography for Yttrium-90 Microsphere Radioembolization [PDF]

Seminars in Interventional Radiology, 2015
Yttrium-90 radioembolization (Y RE) is a contemporary transcatheter locoregional therapy for primary and secondary hepatic malignancies that is commonly utilized in modern Interventional Radiology (IR) practice.1 Unlike other targeted endovascular therapies, such as transarterial chemoembolization (TACE) and transarterial embolization (TAE), the ...
openaire   +2 more sources